Review



rabbit antisars-cov-2 spike protein polyclonal antibody  (MyBiosource Biotechnology)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    MyBiosource Biotechnology rabbit antisars-cov-2 spike protein polyclonal antibody
    Rabbit Antisars Cov 2 Spike Protein Polyclonal Antibody, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibodies+rabbit+polyclonal+antibody+against+sars+cov+2+sp+rbd+sino+biological/human+novel+coronavirus++sars+cov+2++neutralizing+antibody+elisa+kit/pm34862398-191-5-11
    Average 90 stars, based on 1 article reviews
    rabbit antisars-cov-2 spike protein polyclonal antibody - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Recombinant:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Western Blot:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Expressing:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Agglutination:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Control:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Coagulation:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Electron Microscopy:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Disruption:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Functional Assay:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Polymerase Chain Reaction:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Quantitative RT-PCR:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Knockdown:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Staining:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Over Expression:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Stable Transfection:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Flow Cytometry:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Transfection:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Cell Culture:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Concentration Assay:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Gene Expression:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Plasmid Preparation:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Clinical Proteomics:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Enzyme-linked Immunosorbent Assay:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Infection:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Luciferase:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).

    Activity Assay:

    Article Title: Immunogenicity of the CoronaVac vaccine in children: a real-world study
    Article Snippet: Anti-S IgG and anti-S/anti-N IgA antibodies against SARS-CoV-2 (Wuhan P0DTC2 and YP_009724397) were detected in plasma by ELISA (MyBioSource.

    Article Title: CRISPR/Cas9-mediated genomic insertion of functional genes into Lactiplantibacillus plantarum WCFS1
    Article Snippet: After the lysozyme treatment, the cells were washed once with 600 μL PBS and resuspended in a mixture of 1 μL rabbit polyclonal primary antibody against SARS-CoV-2 Spike RBD (MyBioSource) in 50 μL PBS.

    Article Title: SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passages 6 to 8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a protein (MBS157726; MyBioSource) at different concentrations (0.0-4.0 μg/mL for 24 hours) and incubation times (4 μg/mL for 0-60 hours) and then harvested for Western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Targeting iRhom2/ADAM17 attenuates COVID-19-induced cytokine release from cultured lung epithelial cells
    Article Snippet: To evaluate the effect of SARS-CoV-2 on inflammatory responses, bronchial epithelial cells were stimulated with SARS-CoV-2 pseudo-viral particles (MyBioSource, MBS434275) with a multiplicity of infection, MOI = 10.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARS-CoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
    Article Snippet: Anti-nucleocapsid protein antibody seropositivity was measured using the SARSCoV-2 NP IgG ELISA Kit (My Biosource, MBS398004) following the kit manual instructions; sera were incubated in a recombinant nucleocapsid protein pre-coated well followed by HRP-conjugated solution at room temperature for an hour.

    Article Title: SARS-CoV-2 ORF7a activates endothelium to release von Willebrand factor that promotes thrombosis
    Article Snippet: At passage 6-8, HUVECs were incubated with recombinant SARS-CoV-2 Orf7a recombinant protein (MBS157726; MyBioSource, San Diego, CA) at different concentrations (0.0-4.0 μg/mL for 24 hrs) and for varying incubation times (4 μg/mL for 0- 60 hrs), then harvested for western blot analysis and fluorescent immunochemistry for VWF at the indicated concentrations.

    Article Title: Ultrafast and highly sensitive detection of SARS-CoV-2 spike protein by field-effect transistor graphene-based biosensors.
    Article Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etiological agent for the coronavirus disease 2019 (COVID-19), has resulted in over 775 million global infections.. Early diagnosis remains pivotal for effective epidemiological surveillance despite the availability of vaccines.. Antigen-based assays are advantageous for early COVID-19 detection due to their simplicity, cost-effectiveness, and suitability for point-of-care testing (PoCT).



    Similar Products

    96
    Sino Biological antibodies rabbit polyclonal antibody against sars cov 2 sp rbd sino biological
    Antibodies Rabbit Polyclonal Antibody Against Sars Cov 2 Sp Rbd Sino Biological, supplied by Sino Biological, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibodies+rabbit+polyclonal+antibody+against+sars+cov+2+sp+rbd+sino+biological/SARS-CoV-2+(2019-nCoV)+Spike+RBD+Antibody%2C+Rabbit+PAb%2C+Antigen+Affinity+Purified/pm35854977-180-0-7
    Average 96 stars, based on 1 article reviews
    antibodies rabbit polyclonal antibody against sars cov 2 sp rbd sino biological - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    Image Search Results